Drugs / pNGVL4a-CRT/E7 (detox) DNA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01493154 | Apr 2012 → Oct 2015 | head and neck cancer | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pNGVL4a-CRT/E7 (detox) DNA vaccine | “Patients will receive intramuscular needle injections of pNGVL4a-CRT/E7 (detox) DNA vaccine using the TDS-IM device on Day 1, 22, and 43 for a total of three vaccinations per patient.” NCT01493154 ↗ |
| Modality | Vaccine | “pNGVL4a-CRT/E7 (detox) DNA vaccine” NCT01493154 ↗ |
| Route | Intramuscular | “Patients will receive intramuscular needle injections of pNGVL4a-CRT/E7 (detox) DNA vaccine” NCT01493154 ↗ |